Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Sénellart · SciRah

Researcher profile · Semantic Scholar

H. Sénellart

Share profile

H. Sénellart — researcher profile on SciRah

h-index: 24
Works: 115
Citations: 3,583

Most-cited papers

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
T. Kojima, M. Shah, K. Muro, E. François +23 more
2020Journal of Clinical Oncology801 citations Open access
Semantic Scholar
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
P. Paik, E. Felip, R. Veillon, H. Sakai +31 more
2020New England Journal of Medicine710 citations Open access
Semantic Scholar
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients
F. Denis, C. Lethrosne, N. Pourel, O. Molinier +15 more
2017Journal of the National Cancer Institute452 citations Open access
Semantic Scholar
Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study
B. Besse, S. Le Moulec, J. Mazières, H. Sénellart +18 more
2015Clinical Cancer Research218 citations Open access
Semantic Scholar
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase 2 LEAP-005 study.
L. Villanueva, Zarnie Lwin, H. Chung, C. Gomez-Roca +16 more
2021Journal of Clinical Oncology76 citations
Semantic Scholar
LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours
Zarnie Lwin, C. Gomez-Roca, E. Saâda-Bouzid, E. Yáñez +13 more
202066 citations Open access
Semantic Scholar
Phase II study of tepotinib in NSCLC patients with METex14 mutations.
P. Paik, R. Veillon, A. Cortot, E. Felip +16 more
2019Journal of Clinical Oncology61 citations
Semantic Scholar
LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the colorectal cancer cohort.
C. Gomez-Roca, E. Yáñez, S. Im, Eduardo Castañón Álvarez +12 more
2021Journal of Clinical Oncology59 citations
Semantic Scholar
Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study
A. Lim, S. Le Sourd, H. Sénellart, D. Luet +8 more
2017Clinical colorectal cancer57 citations
Semantic Scholar
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis
J. Blanc, F. Khemissa, J. Bronowicki, C. Montérymard +60 more
2021Hepatology International48 citations Open access
Semantic Scholar
A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
F. Dumont, C. Passot, J. Raoul, V. Képénékian +9 more
2020European Journal of Cancer47 citations
Semantic Scholar
PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
Frédéric Dumont, V. Képénékian, Christophe Passot, Anne-Cécile Ezanno-Manasterski +11 more
2024European Journal of Surgical Oncology46 citations Open access
Semantic Scholar
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
T. Aparicio, M. Ducreux, R. Faroux, E. Barbier +305 more
2018European Journal of Cancer41 citations Open access
Semantic Scholar
Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: Results of phase III randomized trial.
F. Denis, C. Lethrosne, N. Pourel, O. Molinier +16 more
201639 citations
Semantic Scholar
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design
F. Dumont, H. Sénellart, F. Pein, L. Campion +4 more
2018Pleura and Peritoneum34 citations Open access
Semantic Scholar
Characteristics of BRAF V600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients.
C. de la Fouchardiére, R. Cohen, D. Malka, R. Guimbaud +16 more
2019The Oncologist32 citations Open access
Semantic Scholar
Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.
J. Bennouna, C. Borg, J. Delord, F. Husseini +9 more
2012Clinical colorectal cancer32 citations
Semantic Scholar
Human T(H)17 immune cells specific for the tumor antigen MAGE-A3 convert to IFN-γ-secreting cells as they differentiate into effector T cells in vivo.
A. Hamai, P. Pignon, Isabelle Raimbaud, Karine Duperrier-Amouriaux +6 more
2012Cancer Research32 citations
Semantic Scholar
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181
A. Adenis, A. Kulkarni, G. Girotto, C. de la Fouchardiére +9 more
2021Journal of Clinical Oncology30 citations Open access
Semantic Scholar
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.
S. Valmary-Degano, P. Colpart, L. Villeneuve, F. Monnien +94 more
2017European Journal of Surgical Oncology28 citations Open access
Semantic Scholar
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer
J. Bennouna, M. Deslandres, H. Sénellart, C. D. de-Labareyre +5 more
2015Investigational new drugs28 citations
Semantic Scholar
Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.
J. Bennouna, H. Sénellart, S. Hiret, N. Vaissière +1 more
2011Lung Cancer27 citations
Semantic Scholar
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
A. González-Martín, H. C. Chung, E. Saâda-Bouzid, E. Yáñez +11 more
2024Gynecologic Oncology24 citations Open access
Semantic Scholar
Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors
P. Girot, Clotilde Dumars, J. Mosnier, L. Muzellec +7 more
2017European Journal of Gastroenterology and Hepathology22 citations
Semantic Scholar
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
C. Ansquer, Y. Touchefeu, A. Faivre-Chauvet, C. Leux +11 more
2020Clinical Nuclear Medicine20 citations
Semantic Scholar
Randomized trial comparing a web-mediated follow-up via patient-reported outcomes (PRO) vs. routine surveillance in lung cancer patients: Final results.
F. Denis, E. Basch, C. Lethrosne, N. Pourel +12 more
201820 citations
Semantic Scholar
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors
P. Girot, E. Baudin, H. Sénellart, N. Bouarioua +14 more
2021Neuroendocrinology19 citations Open access
Semantic Scholar
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis
N. Benzerdjeb, P. Dartigues, V. Képénékian, S. Valmary-Degano +91 more
2021Virchows Archiv18 citations
Semantic Scholar
Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives
O. Capitain, V. Seegers, J. Metges, R. Faroux +8 more
2020Dose-Response17 citations Open access
Semantic Scholar
Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study
T. Mazard, L. Cayrefourcq, F. Perriard, H. Sénellart +12 more
2021Cancers16 citations Open access
Semantic Scholar
Final overall survival (OS) results of a noncomparative phase II study of bevacizumab (B) plus first-line chemotherapy or second-line erlotinib (E) in nonsquamous NSCLC (ns-NSCLC) patients with asymptomatic untreated brain metastases (BM) (BRAIN).
B. Besse, S. Le Moulec, H. Sénellart, J. Mazières +6 more
201316 citations
Semantic Scholar
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27).
E. Samalin, C. de la Fouchardiére, S. Thézénas, V. Boige +17 more
2020Clinical colorectal cancer15 citations Open access
Semantic Scholar
Delineation of the infrequent mosaicism of KRAS mutational status in metastatic colorectal adenocarcinomas
C. Bossard, S. Küry, P. Jamet, H. Sénellart +6 more
2012Journal of Clinical Pathology14 citations
Semantic Scholar
Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study.
Mathilde Cabart, J. Frenel, L. Campion, J. Ramée +5 more
2016Clinical colorectal cancer13 citations
Semantic Scholar
Postoperative hepatic arterial chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: A multicenter randomized phase II trial (PRODIGE 43 - PACHA-01).
M. Gelli, J. Ewald, M. Tanguy, G. Passot +16 more
2023Journal of Clinical Oncology10 citations
Semantic Scholar
Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer
L. Vaugier, X. Mirabel, I. Martel-Lafay, S. Racadot +7 more
2021Cancers10 citations Open access
Semantic Scholar
Effective Management of 177Lu-DOTA0-Tyr3-Octreotate Extravasation.
B. Maucherat, N. Varmenot, V. Fleury, H. Sénellart +1 more
2020Clinical Nuclear Medicine10 citations
Semantic Scholar
Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET
A. Lugat, E. Frampas, Y. Touchefeu, E. Mirallié +13 more
2023Cancers9 citations Open access
Semantic Scholar
Transient Vision Loss − A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases
L. Ah-thiane, J. Raoul, S. Hiret, H. Sénellart +2 more
2021Case Reports in Oncology9 citations Open access
Semantic Scholar
Results of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients
J. Blanc, F. Khemissa, J. Bronowicki, C. Montérymard +15 more
20189 citations
Semantic Scholar
Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer
Y. Touchefeu, Marie Provost-Dewitte, T. Lecomte, A. Morel +12 more
2016European Journal of Gastroenterology and Hepathology9 citations
Semantic Scholar
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study
A. Trécourt, Naoual Bakrin, O. Glehen, W. Gertych +109 more
2024Annals of Surgical Oncology8 citations Open access
Semantic Scholar
Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis
M. Lelong, J. Raoul, Y. Touchefeu, Jean-marie Berthelot +3 more
2022Clinical Case Reports8 citations Open access
Semantic Scholar
Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components
J. Raoul, M. Heymann, F. Dumont, A. Morel +2 more
2021Frontiers in Oncology8 citations Open access
Semantic Scholar
Significance of lymph node involvement in local recurrence of colorectal cancer
F. Dumont, M. Muñoz, V. Franco, R. Wernert +10 more
2019Journal of Surgical Oncology8 citations
Semantic Scholar
Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid.
S. Théoleyre, I. Masson, G. Herbreteau, A. Vallée +2 more
2017Lung Cancer8 citations
Semantic Scholar
[KRAS mutation does not influence oxaliplatin or irinotecan efficacy, in association with bevacizumab, in first line treatment of metastatic colorectal cancer].
Mathilde Cabart, J. Frenel, L. Campion, J. Ramée +5 more
2016Bulletin du Cancer8 citations
Semantic Scholar
Retrorectal Mucinous Adenocarcinoma Arising from a Tailgut Cyst: A Case Report
M. Baverez, E. Thibaudeau, V. Libois, O. Kerdraon +2 more
2021Case Reports in Oncology7 citations Open access
Semantic Scholar
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patients.
J. Delhorme, J. Ohayon, S. Gouy, G. Avérous +97 more
2019European Journal of Surgical Oncology7 citations
Semantic Scholar
Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?
Clotilde Dumars, F. Foubert, Y. Touchefeu, N. Régenet +3 more
2016Endocrine7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Bennouna×13
Invite
J. Bennouna — researcher profile on SciRah
Y. Touchefeu×13
Invite
Y. Touchefeu — researcher profile on SciRah
S. Hiret×10
Invite
S. Hiret — researcher profile on SciRah
E. Thibaudeau×9
Invite
E. Thibaudeau — researcher profile on SciRah

T. Matysiak-Budnik

×7

Invite

T. Matysiak-Budnik — researcher profile on SciRah

Invite

F. Dumont — researcher profile on SciRah

Invite

J. Raoul — researcher profile on SciRah

E. François×6

Invite

E. François — researcher profile on SciRah

C. de la Fouchardiére×6

Invite

C. de la Fouchardiére — researcher profile on SciRah

Invite

O. Glehen — researcher profile on SciRah

J. Douillard×6

Invite

J. Douillard — researcher profile on SciRah

Invite

R. Faroux — researcher profile on SciRah